Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forest Hopes Efficacy In Blacks And Tolerability Will Set Bystolic Apart

Executive Summary

With approval of Forest/Mylan's Bystolic (nebivolol) - the newest member of a crowded beta blocker class - the company is gearing up to launch with an experienced sales force, data to differentiate the drug, and a price in line with one of the most commonly used drugs in the class
Advertisement

Related Content

Watson Seeks Partner For Rapaflo: Is There Still A Market For “Me-Too’s”?
Watson Seeks Partner For Rapaflo: Is There Still A Market For “Me-Too’s”?
Rapaflo Approved For BPH; Watson Will Stress Unique Selectivity
Rapaflo Approved For BPH; Watson Will Stress Unique Selectivity
Risk Info Should Be In Ad, Not Attached Label, FDA Says In Bystolic Ad Letter
Q1 Earnings Calls, In Brief
Bystolic correction
Nebivolol Education Efforts Will Tout Performance In Hypertension Subgroups
Nebivolol Education Efforts Will Tout Performance In Hypertension Subgroups
NitroMed Aims To Revive BiDil With CEO Change, Managed Care Push
Advertisement
UsernamePublicRestriction

Register

PS049152

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel